ESSA Pharma Valuation
| EPIX Stock | USD 6.25 0.15 2.34% |
At this time, the firm appears to be undervalued. ESSA Pharma shows a prevailing Real Value of $9.46 per share. The current price of the firm is $6.25. Our model computes the value of ESSA Pharma from evaluating the firm fundamentals such as Current Valuation of 141.38 M, return on asset of -0.13, and Shares Owned By Insiders of 2.20 % as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors advise acquiring undervalued instruments and dropping overvalued instruments since, at some point future time, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting ESSA Pharma's valuation include:
Price Book 2.4842 | Enterprise Value 141.4 M | Enterprise Value Ebitda (8.09) |
Undervalued
Today
Please note that ESSA Pharma's price fluctuation is slightly risky at this time. Calculation of the real value of ESSA Pharma is based on 3 months time horizon. Increasing ESSA Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ESSA Pharma is useful when determining the fair value of the ESSA stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ESSA Pharma. Since ESSA Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ESSA Stock. However, ESSA Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.25 | Real 9.46 | Target 19.4 | Hype 6.25 | Naive 6.58 |
The real value of ESSA Stock, also known as its intrinsic value, is the underlying worth of ESSA Pharma Company, which is reflected in its stock price. It is based on ESSA Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ESSA Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ESSA Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ESSA Pharma helps investors to forecast how ESSA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ESSA Pharma more accurately as focusing exclusively on ESSA Pharma's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ESSA Pharma's intrinsic value based on its ongoing forecasts of ESSA Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ESSA Pharma's closest peers. When choosing an evaluation method for ESSA Pharma, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
ESSA Pharma Investments |
|
ESSA Valuation Drivers Correlation
Many accounts on the financial statements of ESSA Pharma are highly interrelated and sometimes correlated. Consequently, when conducting ESSA's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of ESSA
Click cells to compare fundamentals
ESSA Valuation Trend
Knowing ESSA Pharma's actual value is paramount for traders to make sound investment determinations. ESSA Pharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of ESSA Pharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both ESSA Pharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
ESSA Market Cap
ESSA Pharma is rated # 2 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 2.99 Billion. ESSA Pharma holds roughly 285.15 Million in market capitalization claiming about 10% of equities under Health Care industry.ESSA Pharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ESSA Pharma's current stock value. Our valuation model uses many indicators to compare ESSA Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ESSA Pharma competition to find correlations between indicators driving ESSA Pharma's intrinsic value. More Info.ESSA Pharma is rated # 3 in price to earning category among related companies. It is rated # 3 in price to book category among related companies . Price To Book Ratio is likely to rise to 0.88 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value ESSA Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ESSA Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ESSA Pharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ESSA Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ESSA Pharma and how it compares across the competition.
About ESSA Pharma Valuation
The stock valuation mechanism determines the current worth of ESSA Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ESSA Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ESSA Pharma based exclusively on its fundamental and basic technical indicators. By analyzing ESSA Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ESSA Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ESSA Pharma. We calculate exposure to ESSA Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ESSA Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -106.6 K | -101.3 K | |
| Pretax Profit Margin | -53.9 K | -56.6 K | |
| Operating Profit Margin | -81.5 K | -85.5 K | |
| Net Loss | -54.5 K | -57.2 K | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct ESSA Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ESSA Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ESSA Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ESSA Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ESSA Pharma's revenue streams: Identify ESSA Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ESSA Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ESSA Pharma's growth potential: Evaluate ESSA Pharma's management, business model, and growth potential.
- Determine ESSA Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ESSA Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ESSA Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ESSA Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 44.1 M |
ESSA Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of ESSA Pharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ESSA we look at many different elements of the entity such as ESSA's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. ESSA Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final ESSA Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ESSA Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ESSA Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ESSA Pharma's worth.When determining whether ESSA Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ESSA Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Essa Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Essa Pharma Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.